- NSE
- MANKIND
- BSE
- 543904
- ISIN
- INE634S01028
MANKIND PHARMA
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹2,668.30
+₹128.30 (+5.05%)
NSE close ·
MANKIND PHARMA closed at ₹2,668.30 on 9 Nov 2026, up 5.05% on the day, and is up 17.97% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹1,927.40 to ₹2,668.30.
Price returns, excl. dividends. 3Y and Max are annualised. 5Y appears once the stock has that much history.
Fundamentals
- Market cap
- ₹1,10,213 Cr
- P/E (TTM)
- 49.2
- Industry P/E
- 35.5
- EPS (TTM)
- ₹54.24
- P/B
- 6.27
- Book value
- ₹425.67
- ROE
- 12.8%
- ROCE
- 14.7%
- Debt/equity
- 0.31
- Operating margin
- 19.8%
- Net margin
- 14.6%
- Dividend yield
- 0.00%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +11.57% | — |
| Net profit | +27.60% | — |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹4,433 Cr | ₹716 Cr | +37.67% | ₹17.20 |
| Jun 2026 | ₹4,076 Cr | ₹574 Cr | +29.12% | ₹13.74 |
| Mar 2026 | ₹3,557 Cr | ₹559 Cr | +31.74% | ₹13.41 |
| Dec 2025 | ₹3,640 Cr | ₹414 Cr | +7.64% | ₹9.89 |
| Sep 2025 | ₹3,789 Cr | ₹520 Cr | −21.05% | ₹12.38 |
| Jun 2025 | ₹3,650 Cr | ₹445 Cr | −18.13% | ₹10.60 |
| Mar 2025 | ₹3,331 Cr | ₹425 Cr | −10.90% | ₹10.18 |
| Dec 2024 | ₹3,307 Cr | ₹385 Cr | −16.37% | ₹9.44 |
Armor risk check
MANKIND PHARMA moves about 1.9× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is MANKIND PHARMA's share price today?
MANKIND PHARMA (NSE: MANKIND) closed at ₹2,668.30 on 9 Nov 2026, up 5.05% from the previous close of ₹2,540.00. It traded between ₹2,585.20 and ₹2,705.00 that day.
What are MANKIND PHARMA's 52-week high and low?
Over the last 52 weeks MANKIND PHARMA traded between ₹1,909.70 and ₹2,705.00, adjusted for splits and bonuses.
What are MANKIND PHARMA's NSE symbol, BSE code and ISIN?
MANKIND PHARMA has NSE symbol MANKIND, BSE code 543904, ISIN INE634S01028.
How has MANKIND PHARMA performed over 1, 3 and 5 years?
MANKIND PHARMA's share price return: 1Y +17.97%, 3Y +13.66% a year. Dividends are not included.
Does MANKIND PHARMA pay a dividend?
Yes. MANKIND PHARMA's latest dividend went ex on 8 Aug 2025: Interim · ₹1.00 per share.
What is MANKIND PHARMA's P/E ratio?
MANKIND PHARMA's P/E ratio is 49.2: the ₹2,668.30 close on 9 Nov 2026 over trailing twelve-month EPS of ₹54.24 (consolidated, four quarters to 30 Sep 2026).
What is MANKIND PHARMA's market cap?
MANKIND PHARMA's market cap is ₹1,10,213 Cr at the close on 9 Nov 2026.
Which sector is MANKIND PHARMA in?
MANKIND PHARMA is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how MANKIND PHARMA fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app